Safety Alerts & Recalls

Search all Safety Alerts & Recalls

Latest Alerts

Long-term use of proton pump inhibitors (PPIs) may increase risk of fractures
A recent study published in the Canadian Medical Association Journal supports the findings from a previous study linking the long-term use of proton pump inhibitors, or PPIs, such as esomeprazole (Nexium), lansoprazole (Prevacid), omeprazole (Prilosec), pantoprazole (Protonix), or rabeprazole (Aciphex) with hip fracture in patients older than 50 years of age. The study also found that patients older than 50 years of age who used PPIs for 7 or more years had a higher risk of any osteoporosis-related fracture than patients using it for shorter periods. For more information, please visit: http://www.cmaj.ca/cgi/content/full/179/4/319 and http://jama.ama-assn.org/cgi/content/full/296/24/2947
Learn More

Long-term use of proton pump inhibitors (PPIs) may increase risk of fractures
A recent study published in the Canadian Medical Association Journal supports the findings from a previous study linking the long-term use of proton pump inhibitors, or PPIs, such as esomeprazole (Nexium), lansoprazole (Prevacid), omeprazole (Prilosec), pantoprazole (Protonix), or rabeprazole (Aciphex) with hip fracture in patients older than 50 years of age. The study also found that patients older than 50 years of age who used PPIs for 7 or more years had a higher risk of any osteoporosis-related fracture than patients using it for shorter periods. For more information, please visit: http://www.cmaj.ca/cgi/content/full/179/4/319 and http://jama.ama-assn.org/cgi/content/full/296/24/2947
Learn More

Receive Safety Alerts & Recalls by email or text message.

Register

Date Published Title Drug Source
2008-09-18 Long-term use of proton pump inhibitors (PPIs) may increase risk of fractures Pantoprazole MediGuard CRT
2008-09-18 Long-term use of proton pump inhibitors (PPIs) may increase risk of fractures Rabeprazole MediGuard CRT
2008-09-12 New Safety Information: Rituxan (Rituximab) and Progressive Multifocal Leukoencephalopathy (PML) Rituximab Manufacturer
2008-09-04 TNF Blockers Increase the Risk of Fungal Infections Etanercept FDA
2008-09-04 TNF Blockers Increase the Risk of Fungal Infections Certolizumab FDA
2008-09-04 TNF Blockers Increase the Risk of Fungal Infections Adalimumab FDA
2008-09-04 TNF Blockers Increase the Risk of Fungal Infections Infliximab FDA
2008-09-03 Mix-ups between regular insulin U-100 and insulin U-500 Insulin FDA
2008-09-03 Statins plus fibrates increase risk of muscle problems Simvastatin MediGuard CRT
2008-09-03 Statins plus fibrates increase risk of muscle problems Lovastatin MediGuard CRT
2008-09-03 Statins plus fibrates increase risk of muscle problems Lovastatin and Niacin MediGuard CRT
2008-09-03 Statins plus fibrates increase risk of muscle problems Clofibrate MediGuard CRT
2008-09-03 Statins plus fibrates increase risk of muscle problems Fenofibrate MediGuard CRT
2008-09-03 Statins plus fibrates increase risk of muscle problems Gemfibrozil MediGuard CRT
2008-08-26 Two new cases of progressive multifocal leukoencephalopathy (PML) Natalizumab FDA
2008-08-26 Several lots of DAYTRANA (methylphenidate transdermal system) voluntarily recalled Methylphenidate Manufacturer
2008-08-22 FDA Is Reviewing Results From a Recent Clinical Trial of Vytorin Ezetimibe with Simvastatin FDA
2008-08-22 FDA Is Reviewing Results From a Recent Clinical Trial of Vytorin Ezetimibe FDA
2008-08-21 Inhaled insulin Exubera no longer available after September 1, 2008 Manufacturer
2008-08-21 Drug Shortage Manufacturer